2021 annual financial data
Corbus Pharmaceuticals Holdings 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -5,464.83%.
Operating income was -55,989,024 USD and net income was -45,552,588 USD.
Operating cash flow was -48,183,697 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 881,705 USD
- Operating income
- -55,989,024 USD
- Net income
- -45,552,588 USD
- Operating cash flow
- -48,183,697 USD